Microorganisms (Mar 2022)

A Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut!

  • Arezina Kasti,
  • Konstantinos Petsis,
  • Sophia Lambrinou,
  • Konstantinos Katsas,
  • Maroulla Nikolaki,
  • Ioannis S. Papanikolaou,
  • Erifili Hatziagelaki,
  • Konstantinos Triantafyllou

DOI
https://doi.org/10.3390/microorganisms10040751
Journal volume & issue
Vol. 10, no. 4
p. 751

Abstract

Read online

Among other factors, food intolerance is cardinal in triggering irritable bowel syndrome (IBS) symptoms in a significant percentage of patients. As a result, specific dietary patterns are the first-line therapeutic approach. The low-FODMAP diet (LFD) is gaining ground as the most well-documented diet intervention that significantly reduces IBS symptoms. Though the LFD improves symptoms, the diet’s impact on intestinal low-grade inflammation, one of the cardinal mechanisms contributing to symptom development, remains doubtful. On the other hand, the Mediterranean diet (MedDiet) is recommended for chronic low-grade inflammation-related diseases because of its anti-inflammatory properties, derived predominantly from olive oil and phenolic compounds. Thus far, the role of a modified LFD, enriched with the MedDiet’s anti-inflammatory components, has not been evaluated in IBS patients. This review aims to examine the hypothesis of a potential combination of the immunomodulatory effects of the MedDiet with the LFD to improve IBS symptoms.

Keywords